Coty Inc.: Form 10-K for the period ended Jun 30, 2023
Filed with the SEC on Aug 22, 2023 and accepted by EDGAR at Aug 22, 2023, 16:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-07-01 to 2023-06-30 | $5.55bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2022-07-01 to 2023-06-30 | $2.01bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2022-07-01 to 2023-06-30 | $3.55bn | us-gaap:GrossProfit |
| Research and development | 12 months2022-07-01 to 2023-06-30 | $105.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2022-07-01 to 2023-06-30 | $2.82bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2022-07-01 to 2023-06-30 | $543.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2022-07-01 to 2023-06-30 | $261.1m | us-gaap:InterestExpense |
| Income tax | 12 months2022-07-01 to 2023-06-30 | $181.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-07-01 to 2023-06-30 | $508.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-07-01 to 2023-06-30 | $0.57 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-07-01 to 2023-06-30 | $0.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-07-01 to 2023-06-30 | 886,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-07-01 to 2023-06-30 | $625.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-07-01 to 2023-06-30 | $222.8m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2023-06-30 | $246.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-06-30 | $2.05bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-06-30 | $12.66bn | us-gaap:Assets |
| Current liabilities | At period end2023-06-30 | $2.74bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-06-30 | $8.43bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-06-30 | $4.18bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-06-30 | $57.9m | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2023-06-30 | $0 | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-06-30 | $3.81bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001024305-23-000060. Last ingested by Listed: Nov 5, 2026, 18:58 ET. Listed shows no prices and gives no investment advice.